- $5.52bn
- $6.47bn
- $1.33bn
Haemonetics Corp expected to post earnings of 73 cents a share - Earnings Preview
Brief: Haemonetics Receives FDA Clearance For Enhancements To NexSys PCS Plasma Collection System
Haemonetics Corp reports results for the quarter ended in March - Earnings Summary
Brief: Haemonetics Q4 revenue USD 304.4 million
Haemonetics Corp expected to post earnings of 70 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-BP, Chipotle Mexican Grill, Hain Celestial Group
Haemonetics Corp reports results for the quarter ended in December - Earnings Summary
Brief: Haemonetics Corp Reports Financial Results For Third Quarter Fiscal 2023
Haemonetics Corp expected to post earnings of 80cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kosmos Energy, Scisparc, Walgreens
U.S. STOCKS ON THE MOVE-IAA, Fluor, Oyster Point
Haemonetics climbs on strong Q2 results, raises FY forecast
Haemonetics Corp reports results for the quarter ended in September - Earnings Summary
Brief: Haemonetics Corp Q2 Fiscal 2023 Revenue Rises 24%
Haemonetics Corp expected to post earnings of 67cents a share - Earnings Preview
NYSE ORDER IMBALANCE 60295.0 SHARES ON SELL SIDE
U.S. RESEARCH ROUNDUP-Abiomed, McDonald's, S&P Global
Brief: Haemonetics Corp Appoints Roy Galvin As President, Global Plasma And Blood Center
NYSE ORDER IMBALANCE 52894.0 SHARES ON BUY SIDE